Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Risks, phenotypes and comparison between treatments according to guidelines GOLD and GesEPOC in primary care].

Semergen - 1 Jan 2000

Flor-Escriche X, Sanz Bas A, Álvarez Álvarez S, Zamora Putin V, Monteagudo Zaragoza M

Abstract excerpt

INTRODUCTION: Chronic obstructive pulmonary disease (COPD) is an underdiagnosed pathology with a high morbidity and mortality. Diagnosis and follow-up are mostly carried out in primary care (PC). The objective of our study is to classify COPD patients according to GOLD 2019 and GesEPOC 2017 guidelines. As secondary objectives, to analyze the type of risk and to describe and compare the prescribed treatment with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Administration, Inhalation
Share to Bronchodilator Agents

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cross-Sectional Studies

Share to Muscarinic Antagonists

Share to Phenotype

Share to Primary Health Care

Share to Pulmonary Disease, Chronic Obstructive

Source

Identifiers

PMID: 36201965
DOI: 10.1016/j.semerg.2022.101839

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Risks, phenotypes and comparison between treatments according to guidelines GOLD and GesEPOC in primary care].PMID 36201965Read ↗

Medical Care According to Risk Level and Adaptation to Spanish COPD Guidelines (Gesepoc): The Epoconsul Study.Semantic proximity Read ↗

Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes.Semantic proximity Read ↗

Spanish Guidelines for Management of Chronic Obstructive Pulmonary Disease (GesEPOC) 2017. Pharmacological Treatment of Stable Phase.Semantic proximity Read ↗

Chronic obstructive pulmonary disease: diagnosis and treatment of stable phase of disease; personalized treatment approach using phenotype features of the disease Summary of the 2020-2021 Czech Pneumological and Phthiseological Society position paper.Semantic proximity Read ↗

[PERSONALIZED MEDICINE: CHRONIC OBSTRUCTIVE PULMONARY DISEASE TREATMENT].Semantic proximity Read ↗

"Chronic obstructive pulmonary disease and phenotypes: a state-of-the-art."Semantic proximity Read ↗

Treatment of COPD by clinical phenotypes: putting old evidence into clinical practice.Semantic proximity Read ↗

Recommendations for COPD management in Central and Eastern Europe.Semantic proximity Read ↗

Clinical Phenotypes of COPD: Identification, Definition and Implications for GuidelinesSemantic proximity Read ↗

Clinical phenotypes of COPD: identification, definition and implications for guidelines.Semantic proximity Read ↗

[Expert Meeting on COPD: Personalized Treatment of COPD - Wishful Thinking or Reality?]Semantic proximity Read ↗

Identification and distribution of COPD phenotypes in clinical practice according to Spanish COPD Guidelines: the FENEPOC study.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.